chevron_leftBack
V
As of 15 June 2026, Vector Science and Therapeutics Corp. has a market cap of $53.17M USD, ranking #30157 globally and #4424 in the United States.
It ranks #3273 in the Financial Services sector, and #518 in the Financial Conglomerates industry.
Key Stats
Market Cap
$53.17MUSD
74.33M CAD
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
William Jackson
open_in_new
Website
vectorscience.co
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 22% | 7.9% | 148% | 4K% | 4K% | 4K% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PAIN
ISIN: CA92244M1041
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.4500 CAD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Vector Science and Therapeutics Corp.
Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-directed interventions in musculoskeletal tissue regeneration. The company is based in Mequon, Wisconsin.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: ARCC
|
$13.41B
25K%
|
11.5
|
|
TSX: BBUC
|
$6.77B
13K%
9.46B CAD
|
-
|
|
NYSE: OBDC
|
$5.6B
10K%
|
9.1
|
|
NYSE: HASI
|
$5.22B
10K%
|
28.7
|
|
NYSE: MAIN
|
$4.84B
9K%
|
9.7
|
|
NASDAQ: GBDC
|
$3.51B
7K%
|
10.7
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
STO: INVE-A
|
$120.04B
226K%
1.14T SEK
|
5.9
|
|
KRX: 402340
|
$71.97B
135K%
109.46T KRW
|
12.5
|
|
BVMF: ITSA3
|
$30.93B
58K%
157.1B BRL
|
9.5
|
|
STO: INDU-A
|
$21.94B
41K%
207.94B SEK
|
5.2
|
|
TWSE: 2887
|
$18.94B
36K%
598.03B TWD
|
12.6
|
|
AMS: HAL
|
$17.79B
33K%
15.4B EUR
|
9.6
|
chevron_leftBack